What does spatial biology — total revenues mean?

This metric represents the total gross revenue generated from the sale of products, services, or assay kits associated with the company's spatial biology platform. It serves as a key indicator of market adoption and commercial traction for advanced imaging and biomarker detection technologies within the life sciences research sector. Growth in this segment reflects the company's ability to successfully scale its specialized instrumentation and consumables portfolio to meet the needs of precision medicine and research customers.

Quanterix Corporation QTRX Spatial Biology — Total revenues

Other product segments

Consumable and other products

$21.38M+18.0%

Simoa

$6.68M—

Research services

$4.35M-22.3%

Instruments

$4.1M+56.2%

Other

$3.12M+396%

Service-type warranties

$2.91M+12.1%

Collaboration and license revenue

$560K-27.4%

Similar metrics at other companies

TXGSpatial — Total Revenue

$40.91M+30.9%

TXGSpatial — Revenue

$6.04M-32.2%

TEC

TECHDiagnostics And Spatial Biology — Revenue

$85.59M-4.1%

VAT

VATELife Sciences — Total Revenue

$1.6M-48.4%

MIRLabs and research — Total revenues

$28.3M+5.6%

AZTAServices — Total Revenue

$107.15M+5.6%

Other financials

Income statement

See full

Revenue$36.4M+20.1%

Gross profit$15.6M+4.9%

Operating income-$41.4M-56.9%

Net income-$17.5M+14.5%

EPS (diluted)-$0.37+30.2%

Balance sheet

See full

Cash & equivalents$36.2M-52.7%

Total debt$35.3M-2.9%

Total equity$282.1M-10.8%

Total assets$366.7M-7.5%

Cash flow

See full

Operating cash flow-$18.1M-30.4%

CapEx$87.0K-93.1%

Free cash flow-$18.2M-20.1%

Valuation

See full

Market cap$203.97M-20.1%

Enterprise value$203.12M+28.6%

P/S1.4×-0.6×

Profitability

See full

Gross margin44.2%-14.3pp

Operating margin-96.9%-1,691pp

Net margin-71.9%-2,019pp

FCF margin-57.2%-220pp

Returns & leverage

See full

Return on equity-34.8%-122pp

Debt / equity0.1×0.0×

Current ratio3.7×-4.6×

Where this comes from

Reported directly by Quanterix Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's spatial biology — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Quanterix Corporation's spatial biology — total revenues?: Quanterix Corporation (QTRX) reported spatial biology — total revenues of $3.7M in Q1 2026.
What does spatial biology — total revenues mean?: This metric represents the total gross revenue generated from the sale of products, services, or assay kits associated with the company's spatial biology platform. It serves as a key indicator of market adoption and commercial traction for advanced imaging and biomarker detection technologies within the life sciences research sector. Growth in this segment reflects the company's ability to successfully scale its specialized instrumentation and consumables portfolio to meet the needs of precision medicine and research customers.